A T2-weighted MRI-based radiomic signature for disease-free survival in locally advanced cervical cancer following chemoradiation: An international, multicentre study.

Joseph MarsillaJessica WeissXiang Y YeMattea WelchMichael MilosevicHeidi LyngTord HomplandKjersti BruheimTony TadicBenjamin Haibe-KainsKathy Han

Published in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (2024)

An MRI-based radiomic signature can be used as a prognostic biomarker for DFS in patients with locally advanced cervical cancer undergoing chemoradiation.

Keyphrases

locally advanced
rectal cancer
contrast enhanced
free survival
neoadjuvant chemotherapy
squamous cell carcinoma
radiation therapy
magnetic resonance imaging
phase ii study
diffusion weighted imaging
magnetic resonance
computed tomography
lymph node
open label